Author:
Zeligs Kristen P.,Morelli Maria Pia,David Justin M.,Neuman Monica,Hernandez Lidia,Hewitt Stephen,Ozaki Michelle,Osei-Tutu Akosua,Anderson David,Andresson Thorkell,Das Sudipto,Lack Justin,Abdelmaksoud Abdalla,Fantini Massimo,Arlen Philip M.,Tsang Kwong Y.,Annunziata Christina M.
Reference40 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2000
2. Efficacy and safety of avelumab for patients with recurrent or refractory ovarian cancer: phase 1b results from the JAVELIN solid tumor trial;Disis;JAMA Oncol,2019
3. Anti-angiogenic agents in ovarian cancer: past, present, and future;Monk;Ann Oncol,2016
4. The diverse functions of the PD1 inhibitory pathway;Sharpe;Nat Rev Immunol,2018
5. Towards personalized, tumour-specific, therapeutic vaccines for cancer;Hu;Nat Rev Immunol,2018
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献